In May 2015, the FDA issued a drug safety announcement that it was investigating reports that certain type 2 diabetes drugs caused a serious medical condition known as ketoacidosis.
In light of a recent safetyannouncement by the federal Food and Drug Administration, U.S. regulators are reviewing the safety of the diabetes medication, Avandia, which is made by GlaxoSmithKline.